Skip to main navigation

Skip to Content

Kinnate Investor Navigation

Overview
News & Events
- Press Releases
- Events & Presentations
Financial Information
- SEC Filings
- Annual Reports
Corporate Governance
Stock Information
Investor Resources

Price
Change

stock chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Tools

Press Releases

Year

Kinnate Biopharma Inc. Presents Preclinical Data on its Lead FGFR Inhibitor Candidate at the JCA-AACR Precision Cancer Medicine International Conference

Sep 13, 2021

Read More

Kinnate Biopharma Inc. Reports Second Quarter 2021 Financial Results

Aug 16, 2021

Read More

Kinnate Biopharma Inc. to Participate in the 2021 Wedbush PacGrow Healthcare Conference

Jul 27, 2021

Read More

Kinnate Biopharma Inc. to Participate in the William Blair Biotech Focus Conference 2021

Jul 07, 2021

Read More

Kinnate Biopharma Inc. Appoints Helen Sabzevari, Ph.D. to Board of Directors

Jun 28, 2021

Read More

Kinnate Biopharma Inc. Appoints Neha Krishnamohan as CFO and Executive Vice President, Corporate Development and Expands its Leadership Team with Key New Hires

Jun 07, 2021

Read More

Kinnate Biopharma Inc. Presents Preclinical Data From its Lead RAF Inhibitor Candidate KIN-2787 at ASCO 2021

Jun 04, 2021

Read More

Kinnate Biopharma Inc. to Participate at the Goldman Sachs 42nd Annual Global Healthcare Conference

May 25, 2021

Read More

Kinnate Biopharma Inc. Reports First Quarter 2021 Financial Results and Announces FDA Clearance of Investigational New Drug Application for KIN-2787

May 17, 2021

Read More

Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture

May 13, 2021

Read More

Pagination

Current page 1
Page 2
Next page
Last page

© 2021 Kinnate Biopharma

Kinnate Footer Legal

Terms of Use
Privacy